Atlas Trials

Autologous Hematopoietic Stem Cell Transplantation for Neurological Damage Associated With Hereditary Homocysteine Remethylation Disorders

Clinical trial NCT07757685 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07757685
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hereditary Homocysteine Remethylation Disorder
Start date
2026-08-01
Primary completion
2030-07-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.